Fulcrum Therapeutics, Inc. is currently listed on NASDAQ under FULC. One share of FULC stock can currently be purchased for approximately $6.77. Is Fulcrum Therapeutics, Inc. a publicly traded stock?

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

Looking for a comprehensive and reliable source of stock market news? Benzinga creates actionable, market-moving stock news content that is all written in-house. Benzinga’s editorial team cuts through ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...